Immucell (ICCC) Interest Coverage Ratio (2010 - 2026)
Immucell's (ICCC) quarterly Interest Coverage Ratio came in at 0.38 in Q4 2025, down 107.61% YoY from 4.98 in Q4 2024, and down 13400.12% on a QoQ basis from 0.0 in Q3 2025.
Immucell (ICCC) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Interest Coverage Ratio data on file, last reported at 0.38 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 107.61% year-over-year to 0.38 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.9 (up 150.66% YoY) and the FY2025 annual result came in at 0.33, up 193.77% from the prior year.
- Interest Coverage Ratio declined to 0.38 in Q4 2025, from 0.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.74 in Q1 2025 to a low of 25.07 in Q1 2023.
- A 5-year average of 1.88 and a median of 0.19 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 5677.24% — and 2025, when it surged 476.83%.
- Tracing ICCC's Interest Coverage Ratio over 5 years: stood at 1.96 in 2021, then plunged by 992.07% to 17.44 in 2022, then jumped by 107.42% to 1.29 in 2023, then jumped by 284.41% to 4.98 in 2024, then sank by 107.61% to 0.38 in 2025.
- The last three Interest Coverage Ratio figures came in at 0.38 (Q4 2025), 0.0 (Q3 2025), and 0.07 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 1.42 |
| 10 | Immucell | 91.10 Mn | 82.24 Mn | 2.44 Mn | 20.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.23 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 7.74 |
| Dec 31, 2024 | 4.98 |
| Sep 30, 2024 | 0.30 |
| Jun 30, 2024 | 1.20 |
| Mar 31, 2024 | -2.06 |
| Sep 30, 2023 | 1.29 |
| Jun 30, 2023 | 1.15 |
| Mar 31, 2023 | -25.07 |
| Dec 31, 2022 | -17.44 |
| Sep 30, 2022 | -4.84 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | 0.45 |
| Dec 31, 2021 | 1.96 |
| Sep 30, 2021 | 0.25 |
| Jun 30, 2021 | 0.19 |
| Mar 31, 2021 | -4.70 |